These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35379641)

  • 1. A feasibility study evaluating the uptake, effectiveness and acceptability of routine screening of pregnant migrants for latent tuberculosis infection in antenatal care: a research protocol.
    Rahman A; Thangaratinam S; Copas A; Zenner D; White PJ; Griffiths C; Abubakar I; McCourt C; Kunst H
    BMJ Open; 2022 Apr; 12(4):e058734. PubMed ID: 35379641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area.
    Loutet MG; Burman M; Jayasekera N; Trathen D; Dart S; Kunst H; Zenner D
    Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29326327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent tuberculous screening of recent migrants attending language classes: a cohort study and cost analysis.
    Usdin M; Dedicoat M; Gajraj R; Harrison P; Kaur H; Duffield K; Walker CL; Akram Y; Aiyedun V; Mohamed H; Zenner D
    Int J Tuberc Lung Dis; 2017 Feb; 21(2):175-180. PubMed ID: 28234081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial.
    Burman M; Copas A; Zenner D; Hickson V; Gosce L; Trathen D; Ashcroft R; Martineau AR; Abubakar I; Griffiths C; Kunst H
    BMC Public Health; 2019 Nov; 19(1):1598. PubMed ID: 31783742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort study.
    Berrocal-Almanza LC; Harris R; Lalor MK; Muzyamba MC; Were J; O'Connell AM; Mirza A; Kon OM; Lalvani A; Zenner D
    Lancet Infect Dis; 2019 Nov; 19(11):1191-1201. PubMed ID: 31471131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of latent tuberculosis testing of migrants in a college environment in England.
    Walker CL; Duffield K; Kaur H; Dedicoat M; Gajraj R
    Public Health; 2018 May; 158():55-60. PubMed ID: 29567507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
    Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
    Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of nationwide programmatic testing and treatment for latent tuberculosis infection in migrants in England: a retrospective, population-based cohort study.
    Berrocal-Almanza LC; Harris RJ; Collin SM; Muzyamba MC; Conroy OD; Mirza A; O'Connell AM; Altass L; Anderson SR; Thomas HL; Campbell C; Zenner D; Phin N; Kon OM; Smith EG; Lalvani A
    Lancet Public Health; 2022 Apr; 7(4):e305-e315. PubMed ID: 35338849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020.
    Margineanu I; Rustage K; Noori T; Zenner D; Greenaway C; Pareek M; Akkerman O; Hayward S; Friedland JS; Goletti D; Stienstra Y; Hargreaves S;
    Euro Surveill; 2022 Mar; 27(12):. PubMed ID: 35332865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivering multi-disease screening to migrants for latent TB and blood-borne viruses in an emergency department setting: A feasibility study.
    Hargreaves S; Nellums LB; Johnson C; Goldberg J; Pantelidis P; Rahman A; Friedland FMedSci JS
    Travel Med Infect Dis; 2020; 36():101611. PubMed ID: 32126293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-sectional study of prevalence and risk factors, and a cost-effectiveness evaluation of screening and preventive treatment strategies for latent tuberculosis among migrants in Singapore.
    Lim VW; Wee HL; Lee P; Lin Y; Tan YR; Tan MX; Lin LW; Yap P; Chee CB; Barkham T; Lee V; Chen M; Ong RT
    BMJ Open; 2021 Jul; 11(7):e050629. PubMed ID: 34266845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to reach and motivate migrant communities at high risk for TB to participate in a latent tuberculosis infection screening program: a community-engaged, mixed methods study among Eritreans.
    Spruijt I; Haile DT; Erkens C; van den Hof S; Goosen S; Ten Kate A; Teshome H; Karels M; Koenders M; Suurmond J
    BMC Public Health; 2020 Mar; 20(1):315. PubMed ID: 32164637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-based testing of migrants for infectious diseases (COMBAT-ID): impact, acceptability and cost-effectiveness of identifying infectious diseases among migrants in primary care: protocol for an interrupted time-series, qualitative and health economic analysis.
    Pareek M; Eborall HC; Wobi F; Ellis KS; Kontopantelis E; Zhang F; Baggaley R; Hollingsworth TD; Baines D; Patel H; Haldar P; Patel M; Stephenson I; Browne I; Gill P; Kapur R; Farooqi A; Abubakar I; Griffiths C
    BMJ Open; 2019 Mar; 9(3):e029188. PubMed ID: 30850420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for active and latent TB among migrants in France.
    Luan L; Fraisse P; Cordel H; Charlois C; Méchaï F; Ibanez G; Hargreaves S; Mechain M; Vignier N
    Int J Tuberc Lung Dis; 2021 Nov; 25(11):903-910. PubMed ID: 34686232
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries.
    Campbell JR; Johnston JC; Cook VJ; Sadatsafavi M; Elwood RK; Marra F
    Emerg Infect Dis; 2019 Apr; 25(4):661-671. PubMed ID: 30882302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries.
    Zammarchi L; Casadei G; Strohmeyer M; Bartalesi F; Liendo C; Matteelli A; Bonati M; Gotuzzo E; Bartoloni A;
    BMC Health Serv Res; 2015 Sep; 15():412. PubMed ID: 26399233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into culturally appropriate latent tuberculosis infection (LTBI) screening in NSW: perspectives of Indian and Pakistani migrants.
    Hall J; Kabir TM; Shih P; Degeling C
    Aust N Z J Public Health; 2020 Oct; 44(5):353-359. PubMed ID: 32776658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): protocol for a cluster randomised trial.
    Oxlade O; Trajman A; Benedetti A; Adjobimey M; Cook VJ; Fisher D; Fox GJ; Fregonese F; Hadisoemarto P; Hill PC; Johnston J; Long R; Obeng J; Ruslami R; Valiquette C; Menzies D
    BMJ Open; 2019 Mar; 9(3):e025831. PubMed ID: 30898826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.
    Zenner D; Hafezi H; Potter J; Capone S; Matteelli A
    Int J Tuberc Lung Dis; 2017 Sep; 21(9):965-976. PubMed ID: 28826445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
    Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.